American Public Education, Inc. (APEI) Earnings Call Transcript
March 12, 2026
Earnings Call Speaker Segments
Thanks so much, and welcome, everyone — good afternoon. This is American Public Education's conference call, and we're here to go over what we delivered in the fourth quarter as well as the complete 2025 year. With me today are Angela Selden, our President and Chief Executive Officer; Edward Codispoti, Executive Vice President and Chief Financial Officer; and Gary Janson, our Chief Strategy and Growth Officer. You can find the materials for this call in the Events and Presentations area on APEI's website. Anything we say on this call, and anything in the presentation that comes with it, about APEI and its subsidiaries that isn't a historical fact might be a forward-looking statement, and those rest on management's present expectations, assumptions, estimates, and projections. Such statements carry risks and uncertainties, and because of those, actual results could end up differing materially from what those statements express or imply — for example, the ones we lay out in our Form 10-K under the heading Risk Factors, which include possible effects from government shutdowns or from shifts in federal or state government policies, practices, and laws, among them effects on revenues or on when receivables come in. Certain words can tip you off that you're hearing a forward-looking statement — things like anticipate, believe, seek, could, estimate, expect, can, may, plan, potentially, project, should, will, would, along with similar terms or their opposites. Such statements address, among other things, what we anticipate regarding registration and enrollments, revenue, earnings, adjusted EBITDA and other earnings guidance, the foundation for our growth, the proposed merger of our institutions, actions by government and regulatory bodies, the effects of those actions and how we respond, shifts in market demand, our capacity to meet that demand, and other company initiatives. Non-GAAP financial information is discussed on this call and in the presentation. Every non-GAAP metric we discuss is reconciled to its closest GAAP equivalent—you can find those tables in the appendix of the presentation we're using today, as well as in the earnings release. It's management's view that sharing non-GAAP figures gives investors helpful extra context about operating results; however, such figures are meant to be looked at alongside GAAP measures, never as a replacement for them, nor as carrying more weight than anything calculated under GAAP. With that, I'd like to pass things along to Angela Selden, who serves as President and CEO of APEI. Angie, the floor is yours.
Thanks, Shannon. Good afternoon, everybody. I'm grateful to each of you for joining us today to discuss American Public Education's results for the fourth quarter and the full year 2025. When 2025 began, our goal was to make APEI simpler and stronger. Now I'm very happy to report the outcomes below and to show how what we accomplished in 2025 gives us real momentum as we launch the four-year growth strategy we unveiled at our recent Investor Day. To begin: despite an interruption to fourth quarter registrations, APUS still grew revenue for the full year 2025. Demand from APUS's student population — veterans, extended military families, and service members from every branch — matched what we had anticipated. First, the fundamentals of this business are solid, and you can see that in the figures. Second, we had excellent performances this year from both our nursing and healthcare institutions. Revenue for all of 2025 rose 14% at Rasmussen, while at Hondros it was up 11% for the full year. Third, at APEI, consolidated revenue for the full year climbed 4%, reaching $649 million compared with 2024 — and we got there despite selling Graduate School U.S.A. partway through the year, the two Rasmussen campuses in Wisconsin that we announced would close, and a fourth-quarter registration disruption at APUS that hit TA registrations for 43 days. To put that in perspective, if you take Graduate School U.S.A. out of both 2024 and 2025, consolidated revenue would have been up roughly 7% against the prior year; these results underscore just how strong our diversified portfolio is. Fourth, for the entire year, APEI posted adjusted EBITDA of $85.7 million. That represents growth of 19% over 2024, and it surpassed both the updated guidance we had provided and the highest figure in our original 2025 forecast. We cut expenses throughout the company — particularly at APUS and within APEI Technology — and those reductions established a new, lower cost baseline going into 2026 and afterward. Last, we delivered on our promises. Early in 2025, we pledged to redeem the preferred equity, divest certain corporate buildings, and secure the Department of Education's removal of the $25 million letter of credit along with the 6 years of growth restrictions that had blocked new campuses and new programs at Rasmussen prior to APEI's acquisition. Meeting those commitments made our business simpler and stronger heading into 2026 and afterward, and we hit those targets while also increasing enrollment, widening margins, and improving our balance sheet at the same time. Our teams showed resilience, tenacity, and confidence as they worked past obstacles and produced outstanding results. Let's now shift our focus to consolidated revenue for APEI's fourth quarter of 2025. We posted $158.3 million, and we beat the guidance we most recently provided on every key financial metric, among them revenue, net income available to common stockholders, EPS, and adjusted EBITDA. Our nursing and healthcare institutions showed considerable strength in 4Q25. Rasmussen was up 16%, and enrollments rose 9% year-over-year to roughly 15,900 students, which marks our sixth quarter in a row of year-over-year enrollment growth. The really thrilling part is that our approach of filling every last seat in the back row—getting the most out of the capacity we have—is paying off. Across the board, our nursing programs keep demonstrating strength, and their results are especially impressive. Now, on the allied health side—surgical tech and radiological tech, for example—those are performing nicely as well, though most are at capacity, which creates room for the expansion efforts we have in the pipeline. Squeezing the fullest possible use from existing capacity at the campuses we currently operate generates substantial operating leverage and reveals quite a notable gain in margins. Over at Hondros, results keep coming in strong: 4,000 students enrolled in the fourth quarter of 2025, revenue up almost 10% from a year earlier, and enrollment growth of 9% year over year. That tells you demand for pre-licensure nursing is durable and that we can reach students effectively in the markets where we operate. During the fourth quarter of 2025, APUS made it through the 43-day federal government shutdown, which interrupted course registration for active duty military students. As we've said before, 12 years have passed since the Defense Appropriations Bill — the legislation that funds military tuition assistance, or TA — had gone unsigned by October 1, the start of the federal government's fiscal year; since that bill was still unsigned when our November start came around, all four major military branches started drawing on their share of the $100 million in tuition assistance money authorized under the One Big Beautiful Bill Act so that active duty military students could keep studying. Importantly, after the government reopened in December, TA registrations rose 41% versus December 2024, which shows the resiliency of our military students and their demand for education, even when funding gets disrupted. Because most APUS learners enroll in just one class per term, what happened amounted to a postponement of their academic momentum rather than a complete stop. Beyond that, a clear positive in APUS's Q4 came from sustained strength across our military and veteran family segments, where sign-ups continued climbing at a rate in the upper teens. Turning our attention to 2026 now, there are two significant items I'd like to highlight for the first six months of that year. To begin with, meaningful strides are being made toward bringing our institutions together. The Higher Learning Commission gave the green light in late February to a major milestone in that institutional merger, and then on March 2, we combined the legal entities of all three institutions into a single one; right now, we're collaborating with the Department of Education and HLC to wrap up the remaining work required to unite our three institutions as one system under a single OPE ID. Our target is an expected effective date at the start of Q3 2026, which means it would take effect for the 2026 financial aid award year. In addition, as of today, we are officially announcing two reporting segments — APU Global and RU Health Plus — for fiscal year 2026 and beyond. Also, we plan to launch two new campuses during 2026. The first is a Rasmussen location in Orlando, and it's accepting students now for the second quarter of 2026. The second is a Hondros site in Detroit, and we anticipate it will be prepared to begin enrolling students in the first quarter of 2027. Each represents a key move into areas where demand for our offerings has already proven robust. During our upcoming earnings call, we'll provide additional information and updates regarding these first-half 2026 initiatives. When we consider 2026 overall, we believe the routes toward increasing our revenue and widening our margins are plainly visible. That covers maintaining the strong recruiting trend we've got going at Rasmussen and Hondros, taking the positive results from 2025 and pushing them further, and continuing with both Fill the Back Row and Leverage the Ladder. By bringing Rasmussen and Hondros together, we anticipate revenue synergies will emerge. At APUS, we're budgeting for an acceleration in growth once government funding stabilizes and once the combination gives us greater marketing latitude for military and veteran enrollment. The recent re-refinancing of our debt, along with the associated expense reductions, should allow us to capture improved profitability and cash flow. With all of that in mind, among other factors, we're providing the following guidance for the full year 2026. APEI's 2026 revenue is expected to fall in the range of $685 million to $695 million. We expect adjusted EBITDA to land in the range of $91.5 million to $100.5 million. Turning to our guidance for Q1 2026: because of where we are in the quarter right now, and because of when this call is taking place, we have complete visibility into all university enrollments. As a result, APEI revenue should fall somewhere between $173 million and $175 million. One thing to remember is that the comparable period in 1Q25 included $3.7 million in graduate school revenue, and that obviously won't appear in 2026 since the sale closed in July 2025. Adjusted EBITDA is expected to be between $25.5 million and $27.0 million. Our CFO, Ed Codispoti, will go into further detail during his portion—he'll walk through how enrollment and registration came out in Q1, the debt refinancing we completed, and the approval of a fresh $50 million buyback of shares. As for the road ahead, we know exactly what the coming four years demand from us. Execution is the whole game. With the groundwork in place, a leaner business, and a sturdy balance sheet behind us, we've put a strategy together and we're building up our team—so from here on, it comes down to delivering on our commitments every single quarter. That's the pattern you saw in 2025, and it's the pattern you can count on from us moving forward. Having said that, I'll now hand things over to Ed, who will walk us through the financial results and the 2026 guidance in detail.
Thanks, Angie. I'll start by going over what we delivered in the fourth quarter, after that take you through how we performed across all of 2025, and wrap up with what we expect for the first quarter and the whole of 2026. Revenue on a total basis for Q4 came in at $158.3 million, which is $5.8 million lower, or 3.5%, versus $164.1 million a year earlier. Even with the shutdown of the federal government hitting APUS, we came in above the guidance we had most recently put out; so let's walk through revenue segment by segment. Looking at APUS, Q4 revenue landed at $71 million, a drop of 13.8% from $82.4 million in the same period last year. That decrease stems from the federal government shutdown that occurred across October and November. Net course registrations during the quarter totaled 82,200, a fall of 15.3% from a year ago. Even so, the fundamentals underpinning the business stay solid. Over at Rasmussen, revenue for the fourth quarter reached $66.6 million, climbing 15.9% from $57.5 million in last year's fourth quarter. That strong showing came from enrollment growth of 8.9%, which lifted total students to 15,900. Turning to Hondros College of Nursing, fourth quarter revenue hit $20.7 million, rising 9.2% from $18.9 million a year earlier. That mirrors ongoing enrollment momentum, with 4,000 students, which is up 8.1% versus a year ago. Now let's look at profitability for the quarter. Net income available to common stockholders in Q4 was $12.6 million, or $0.67 per diluted share, against $11.5 million, or $0.63 per diluted share, a year earlier. That works out to a 9.6% rise in net income and a 6.3% rise in diluted EPS. Adjusted EBITDA for the fourth quarter came to $28.7 million, versus $31.4 million in the same period last year, putting the adjusted EBITDA margin at 18.1%. Though it declined from a year ago because of the APUS shutdown impact, we still beat the guidance we had most recently given, which shows solid operational execution. Let me shift to our results for the full year. Across all of 2025, consolidated revenue totaled $648.9 million. That amounts to 3.9% growth compared with 2024, even with the federal government shutdown impact and the divestiture of Graduate School U.S.A.. If you take Graduate School U.S.A. out, if that revenue is removed from both periods, growth in revenue would have come to roughly 7%. APUS revenue totaled $319.8 million, an increase of 0.9% from a year earlier. Rasmussen revenue came to $246.2 million, up 13.9% from the prior year. That growth came from sustained enrollment momentum along with our successful Fill the Back Row strategy. Notably, Rasmussen generated segment income from operations of $4.1 million, versus a loss of $21.8 million in 2024; that's a swing of close to $26 million, which shows strong enrollment growth along with substantial margin expansion. Hondros revenue was $75 million, an 11.4% increase from a year earlier, reflecting ongoing demand for pre-licensure nursing education. Adjusted EBITDA for the full year came to $85.7 million, which is $13.4 million higher, or 18.6%, versus $72.3 million in 2024. That marks a significant accomplishment and shows how strong our business model is, with our adjusted EBITDA margin widening 164 basis points to 13.2% in 2025. For the entire year, net income available to common stockholders came to $25.3 million, which works out to $1.36 per diluted share. That compares with $10.1 million, or $0.55 per diluted share, in 2024. This 152% rise in net income is a reflection of how we executed operationally, the fact that we no longer have preferred dividends after redeeming them in the second quarter, and expansion in our margins. We closed out 2025 with a very strong balance sheet as well. At December 31, 2025, cash equivalents and restricted cash came to $176.5 million, up from $158.9 million at December 31, 2024 — a gain of $17.6 million, or 11%. Total debt stood at $96.4 million, leaving us with a net cash position of $80.1 million. Last Monday, March 9, we refinanced our debt, which further bolstered both our balance sheet and our liquidity. Through that refinancing, at current leverage levels we cut our borrowing rate by roughly 375 basis points and brought our principal balance down from $96.4 million to $90 million. Combining that lower borrowing rate with the smaller principal should deliver $3.7 million in yearly interest expense savings, not counting amortization of debt issuance costs. When you're modeling, assume interest income will be about equal to interest expense in 2026, thanks to our strong cash balances and the improved borrowing rate. We will also record a non-cash write-off of approximately $1.6 million tied to deferred financing costs from our prior loan. Our solid balance sheet and cash generation give us considerable financial flexibility for growth investments. That liquidity position also played a key role in letting us get through the government shutdown without any operational disruption. On top of that, this week our board of directors approved a $50 million share repurchase program; we anticipate using it mainly to offset dilution from share-based compensation, while also giving us flexibility to buy back shares opportunistically depending on market conditions and other factors. This authorization shows the board's confidence in the company's long-term strategy, our strong cash flow profile, and our dedication to disciplined capital allocation. Repurchases could happen from time to time via open market transactions or other permitted methods, and the timing and amount of any repurchases will hinge on market conditions, share price, and alternative uses of capital. I'll now go over our guidance for the first quarter and the full year 2026. For the first quarter of 2026, our guidance is as follows. Revenue between $173 million and $175 million. Net income available to common stockholders between $11.1 million and $12.2 million. Adjusted EBITDA between $25.5 million and $27 million. Diluted earnings per share between $0.58 per share and $0.64 per share. As you consider this guidance, remember that seasonality affects our results. The first quarter is normally our second strongest quarter of the year. For the full year 2026, our guidance is as follows. Revenue between $685 million and $695 million. Net income available to common stockholders between $41.3 million and $47.6 million. Adjusted EBITDA between $91.5 million and $100.5 million. On a diluted basis, earnings per share should land somewhere from $2.15 to $2.47, while CapEx is expected to come in somewhere between $28 million and $32 million. All things considered, APEI had a really strong 2025. Even with headwinds from outside the business, we came in above the guidance we had given, made our balance sheet stronger, and set the company up for faster growth in 2026. Looking at what we're guiding for 2026, it captures ongoing gains in enrollment, better margins, and the payoff from a stronger balance sheet, and we feel we're in a good spot to hit those numbers. With that, I'll hand things back to Angie for the closing remarks.
Appreciate that, Ed. Wrapping things up: across the past twelve months, we set financial and operational goals that push us hard yet remain achievable. In our RU Health Plus segment — covering both Rasmussen University and Hondros College of Nursing — enrollment keeps climbing steadily and profits have improved. As for APU Global, setting aside the temporary dips in enrollment caused by the federal government shutdown, expansion and healthy margins have carried on. Let me go over again the multi-year growth plan we presented at our November 2025 Investor Day. During that event, we described our vision reaching out to 2029, with five major value creation efforts at APU Global plus four inside our RU Health Plus healthcare division. The factors fueling our expansion remain firmly intact. Every one of these value creation efforts strengthens the others, creating a foundation for continued growth. Within our multi-year growth framework, we laid out a projection of organic revenue hitting $890 million-$925 million by 2029 — representing an 8%-9% revenue CAGR — together with adjusted EBITDA margins of 20%-21%. By making strategic investments in new campuses as well as pursuing possible tuck-in acquisitions, we see a potential path to $1 billion in revenue by 2029. APEI as an organization was purpose-built to provide affordable and accessible education opportunities in fields that are in high demand and resilient to disruption. In nursing education, the priority is in-person bedside care, and our military service members remain critical to the U.S. approaches to defense, particularly given the current tense conditions across the Middle East and Latin America. Our view is that professions calling for discernment can withstand AI disruption and will keep requiring people to carry them out. With our platform and favorable industry momentum, APEI is set up to speed up expansion and extend more learning possibilities to a wider group. Our confidence in what this company can achieve over the long run has never been greater than it is right now. Ahead of taking your questions, I'd like to recognize how much we appreciate all the input so many of you have shared. As part of our continuing push to be increasingly open with the investor community, we're dedicated to giving you straightforward visibility into how we're performing, what our strategic efforts look like, and where the possibilities for building worth over the long haul lie. I'd also like, for a moment, to pay tribute to Sergeant First Class Nicole M. Amor — a Rasmussen University alumna and one of six people who lost their lives in Kuwait on March first while in service to her nation. Everyone at APEI holds the values Nicole represents, and her dedication and the ultimate price she paid leave us profoundly thankful. Our sympathies go out to her relatives and to those who served alongside her in the armed forces. With that said, I'd like to turn things over to the operator so we can move into the Q&A portion of the call.
Hello, and good evening. I appreciate you taking my questions, and congratulations on those outstanding results despite, as you know, a challenging macroeconomic environment with the government shutdown during the fourth quarter. I'd like to begin with the CapEx cadence and the increase tied to these new campus openings. Will it be spread evenly across the year, or will it build up toward the latter half as that Hondros campus prepares to begin enrollments?
Yes, Griffin, regarding the campus openings, we anticipate that the bulk of the CapEx for the new campuses will land in the fourth quarter, perhaps a small portion in the third quarter. That's a good question; it will predominantly fall in the second half of the year.
All right, that's excellent. Thank you, Ed, for that. And along those same lines, could you refresh our memory? I realize you covered this during your Investor Day, but I believe it would be useful for everyone here to hear a reminder regarding how the economics work for these new campuses. Specifically, what revenue per new campus do you anticipate once it has ramped, what are the margin expectations, and at what point do you expect to reach cash flow break even? My apologies, I'm not sure whether there's some background noise coming from my side. I'm picking up a bit of that. I could ask the question again if you could—
You sound perfectly clear to me. You're fine. Yeah.
That's not something we're seeing. As we've mentioned, our campuses don't require much capital expenditure. Opening one should run roughly $3.5 million, and it takes somewhere between 8 and 18 months to reach positive cash flow. At scale, based on the economics we've discussed, we'd anticipate a campus generating around $12 million in revenue with an EBITDA margin of about 35%.
Okay, great. Yeah, that's super helpful.
Griffin.
Yeah.
Oh, Griffin, I was about to say, we remain on track to launch 2 campuses each year. That's what the plan currently calls for, and it was built into the 4-year plan that we presented at Investor Day.
All right, yes. I suppose, before I ask my final question, let me just build on what was said there. Should we anticipate, like, somewhat elevated CapEx — at minimum higher than what we'd see at 25 — as we move past 26? I realize you aren't providing guidance on that, but would that be a sensible assumption?
Yes. I believe what Ed mentioned during his remarks regarding the whole year this time around is essentially the typical figure we'd rely on, and that figure accounts for roughly $7 million tied to new campus openings. Would you agree with that?
Yeah, that's reasonable. Yep.
All right, great.
What we're looking at is somewhere from 28 to 32, meaning 7 of that amount relates to campus openings.
Alright, that clears things up. And then only one more thing before I pass it along and rejoin the queue. I get that moving forward there will only be 2 operating segments. But could you possibly give us some idea of what to expect in the first quarter for Rasmussen and Hondros before we begin modeling only 2 divisions going forward?
We're heading toward combining into 2 segments, so we won't be providing that breakdown to the investor community in the future, no.
Okay. Fair, fair enough. Thank you, Angie.
Okay.
Griffin Boss, thanks, Ed. I appreciate that.
Angela Selden here — absolutely. Yes, and I appreciate you asking those questions, Griffin. Many thanks.
Yeah. Hey, everyone. Congrats on a really solid quarter. I suppose I'm interested in getting into the marketing approach and how that changes once the institution combination starts to take hold. Could you sort of walk us through that marketing approach?
Yeah. Excellent question, Luke. So, to begin, I'll say that the Rasmussen name and the Hondros name are going to stay visible in their respective local areas. Those brand names will keep drawing learners to those campuses through the marketing approach. What we're doing is taking the stronger methods from all 3 education units and sharing them with one another. The top methods from APUS go to Rasmussen online. The top methods from Rasmussen campuses go to Hondros, and the reverse as well. We keep fine-tuning where our marketing dollars go. There's a distinction between what we handle digitally, mostly for online students, and what we handle in a more scrappy, ground-level way for our campuses. Across all those brands, we'll keep enrolling students for 2026.
All right, that's useful. And finally, regarding course registrations at APUS, I believe you mentioned a year-over-year increase of about 41% for the month of December. So, when the government shut down and funding was halted, was there a wait list that let students sign up for course registration after funding came back? Or, what actually drove that large spike in December course registrations?
Yes, good question. I'll let Gary take that one. Go ahead.
Right. What I was about to add is that the outcome was a nice surprise, honestly. We had no idea whether the recovery would be sizable or if the drop was simply going to stick around forever, yet we did witness a meaningful rebound among the military students. To me, that points to solid demand having existed, and with no funding available, those people were simply waiting on the sidelines. It was a mix of incoming students plus those already enrolled who returned, and on that front, you know, we lacked any solid signal. That came as a welcome surprise for us in December, and clearly it gave the year a strong start too.
Remember that the 20,600 TA registrations from October and November ultimately got dropped. The students involved had already been attending class, and we were forced to remove them because payment wasn't made. If you ask, "Did a wait list exist?" or something similar, they had already planned to take those courses during October and November. Once funding opened up once more, they came right back, and it made us quite happy that December—the quarter's lightest enrollment month, simply due to the holidays and so forth—appeared not to deter them from returning to their courses.
Alright, understood. That's quite useful. I have no further questions. Nice work on the quarter.
Many thanks, Luke.
Thank you, Luke.
Thank you very much.
Yeah. I also wanted to ask about APUS enrollments, but with more of a focus on the non-TA side. I noticed Q4 was up 11% for non-TA, so I was just wondering — could you remind me how that stacked up against the first nine months of the year? Did that represent an acceleration?
Great question. Eric, I'm going to hand that one over to Gary so he can respond.
Yeah, the non-military parts of the business are something we feel really good about, and as Angie pointed out, we recorded high teens in both the veterans market and the extended family market. Our other category came in somewhat softer, though when you put the non-military active duty segment together, growth was roughly 11% overall.
All right; and regarding Q1, that 4% increase versus the prior year that you recorded — did it continue through the first quarter?
Yes, it did.
What about the number of people signing up?
Sure — chances are we'll share additional detail on that topic when we hold our following call. That said, the very same pattern did carry on, and that makes us quite happy. We believe solid momentum exists in that area, which matches what we'd been anticipating, and we're definitely delighted by how things turned out. Our teams put in serious effort to grow the extended families and the veterans, since those groups typically enroll in additional courses and pay somewhat higher tuition rates. Progress is unfolding at a steady pace, even with a slight dip among active duty members stemming from a partial shutdown in Q1.
Understood. For my final question, I want to ask about how we're deploying cash and what takes precedence. Clearly, you've rolled out a fresh buyback program worth $50 million. You mentioned, in a sense, offsetting equity-based compensation and the dilution it creates. So really, what comes first? Is it that anything past that goes toward reducing debt, or does the present share price look attractive enough to you folks? Where's the emphasis?
Yes, excellent question, Eric. I'll hand it over to Ed so he can address that.
Absolutely. So, in terms of what takes precedence, our initial emphasis will always be on growing organically—that stands as our top objective. We aim to pursue that while keeping our balance sheet cautious. We'll keep evaluating M&A; it needs to be opportunity-driven by nature. There could be situations where geographic expansion appeals to us, or a transaction whose footprint makes strategic sense. Once all those considerations are accounted for, we shift toward giving capital back to shareholders. With this $50 million authorization specifically, like you mentioned, our attention is squarely on stock-based comp dilution and reducing it. If market events arise or the share price moves in a way that creates a sensible opening for us to buy back more opportunistically, we'd act on that too.
Understood. I appreciate you answering my questions.
You're welcome.
Good afternoon, everybody. Perhaps building on a question asked previously — I'd like to know what your 2026 guidance assumes regarding growth in on-ground healthcare, or if you could share any further specifics about healthcare student demand you're observing this year, that would be terrific.
Hello, Jasper. Thank you so much for asking. To begin, I'd note that interest remains robust in our campus offerings, particularly the pre-licensure nursing programs we run on campus. I'll pass things to Gary, who can provide a bit more color on that.
Right, I believe we mentioned that growth ought to look fairly linear when measured against our longer-range strategic plan. What we're aiming for, roughly speaking, is high single digit growth across the whole healthcare platform; our campuses are meant to expand a bit more quickly than the online side and the healthcare division—not in an obvious way, but that's the pace we're after. And of course, getting APUS to grow at a comparable rate, perhaps a little less, just slightly under the healthcare platform.
Appreciate that. It may be a bit soon to tell, though I was hoping you could help us understand whether the conflict with Iran is shaping how your active duty learners at APUS are acting, or perhaps how that segment of your student body has tended to act in the past whenever military operations ramp up.
Excellent question, Jasper. So at this point, we don't have the precise number of troops involved, but the bulk of those deploying come from the Navy, the Air Force, cyber, and certain personnel based regionally. Our biggest enrolled group, you know, is the Army, and the ground deployment has not yet taken place. With the March start, which served as a genuinely significant checkpoint for us to gauge what type of effect, if any, we might see, we found essentially no change in our March start rate, even with the Middle East war; and based on what we've observed across the years with military deployments, we don't expect a notably positive or notably negative effect on registration. Sometimes, you know, individuals pause their schooling since they're deployed and can't be sure they'll have a computer available. We observe others accelerating their schooling because they're deployed yet have spare time along with internet access and a computer, so they choose to enroll in courses; ultimately it all evens out. At this moment we don't believe there will be any meaningful effect at APUS on registrations in, you know, in 2026; we will definitely keep you updated as we find out more.
Understood. Appreciate you fielding this.
You're welcome.
Hello, and thanks for fielding my questions, Raj. The results were excellent and the guidance looks strong, so this has been a real pleasure. I had a few things I wanted to ask. What's your specific plan for filling the back row? I recall you discussed this at the Analyst Day. Could you list some concrete tactics?
Yes. That's a terrific question, Raj, and I appreciate the kind words. Our marketing strategies are now sharply focused on drawing students toward the programs where the supply-demand gap is largest and where local markets show the strongest hiring needs. We're polishing those marketing approaches, and in certain markets we're putting in more marketing dollars than we initially budgeted, since the yield and the results have been excellent. We're aiming to be deliberate while also staying aggressive in how we take the EBITDA outperformance, especially at Rasmussen, and direct a portion of that money into marketing so we can keep expanding and Fill the Back Row. We'll simply keep doing what we did in 2025, and that produced outstanding results. I'll hand it to Gary for additional thoughts.
What I would add is that our intention is to share programs among the campuses; it's a solid portfolio we have. Nursing and allied health offerings differ from one campus to another. Take the strategy behind the new Orlando campus, for instance: in that market we're launching an LPN program, something we previously lacked, and as we evaluate campuses that turns into a further opportunity. So it's partly about keeping up the marketing, and partly about developing — leveraging those campuses and growing programs that might be missing from what they currently offer. Campus by campus, we have a highly detailed plan covering which programs we intend to introduce across the coming four years.
Understood, thanks. That clears things up nicely. So then, you've set the fiscal 2026 guidance for total revenue at just above 6%. From what you mentioned earlier, would it be fair to think nursing at Hondros will be up in the high single digits percentage-wise across the year, expanding faster than APUS?
My apologies. I wasn't trying to interrupt you. Sorry about that. Go ahead and finish what you were asking, Raj. Sorry.
No, I only meant that you separate out the nursing piece along with APUS. Is that right?
Yes.
Would that be the upper single digits and the lower single digits?
Yes, and before anything else, I want to remind everyone reviewing the year-over-year comparisons that Graduate School revenue is present in the first half of 2025. On the Q1 guidance page, we noted that $3.7 million of Graduate School is included in Q1 revenue. As I can see it now, we didn't include the entire Graduate School revenue figure that could be subtracted from the 2025 comparison. Were you to make a like-for-like comparison, at the midpoint our growth rate comes in near 8%. Of course, once you reach the full year, you'll also, you know, be in a position to observe that we'd probably be able to bring back the enrollment we had to give up during October and November because of the government shutdown. In our view, those numbers contain some puts and takes indicating that roughly 8% is likely for the midpoint of our full year, with APUS, as you mentioned, in the mid-single digits and our healthcare schools at the high single to low double digits. Yes.
Thanks. That's quite useful. So, building on that previous question, with revenue growth at Rasmussen and Hondros, you've generated incremental margins, correct? I believe in the prior year — fiscal 2024 and 2025 — it exceeded 50%, and this year, based on fiscal 2026 guidance, it appears to be implied. The incremental profit margins come out to 25% based on that guidance. Are you expecting stronger incremental profit margins than what the guidance suggests?
Clearly, this is Gary speaking. I believe we're clearly on track for that. We're putting some strategic investments in place to ensure we can reach those figures. Angie talked about some marketing. In the prior year, I think we achieved 75% flow-through margins at Rasmussen for the full year. We'll keep watching that, but it will build over the course of the year. I think at this moment we're making sure we remain focused on solid top-line growth to fill the back row, and that could involve some extra S&M spending and some faculty ahead of that. Keep in mind the campuses as we move forward — they will dampen the margins somewhat, not so much in 2026, but in later years.
The new campuses.
New campuses, sorry.
Which we didn't have any campuses.
Um-
Yeah, in the Rasmussen numbers in 2025.
All right, we can pick this up later. Thanks once more. Wonderful numbers and solid outlook, and I appreciate your time on my questions.
Thanks, Raj.
Thanks, Raj.
Thank you very much.
Hi, everybody. Matt Filek here, filling in for Stephen Sheldon. Nice work on wrapping up the year so well, and I appreciate you fielding my questions. I'd like to begin with a brief follow-up regarding Fill the Back Row. I believe you've mentioned before that utilization at nursing campuses sits at roughly 60% right now, though your goal is nearer to 90%. Could you share anything about the approximate timeline and pace for reaching that 90% level across the nursing campuses?
Yes. Hello, Matt. That's a wonderful question. It happens to be the subject we enjoy most. Back at Investor Day, we indicated that we'd be getting close to that 90% by the time we reach year four; we also indicated that we anticipate a fairly steady climb across those four years. Our view is that this will essentially involve filling up capacity and bringing in students along a fairly even path throughout the coming four years.
Understood. Yes, that's completely logical. I just have a brief question regarding teacher capacity. What's your sense of how your current instructor capacity looks throughout the educational units? Is there anywhere you might be a bit overstaffed or understaffed?
Excellent question. I believe if you recall during the Investor Day meeting, we discussed briefly the importance of ensuring that we aren't merely enrolling students, but that we're also handling those constraints, correct? Ensuring that every essential resource is available, including faculty, clinical availability, and so on, right? The positive side is, given that we're, you know, well beyond COVID at this point, faculty availability truly hasn't been a limiting factor in our markets recently, which is truly great news since that is definitely among the things that creates difficulty for you to, you know, enroll at the rates that we were enrolling at. At present, we don't have any campuses experiencing a faculty shortage. As a matter of fact, every one of our dean positions is filled across all of our Rasmussen and Hondros campuses. From a talent and faculty standpoint, we genuinely believe we're entering 2026 in a very strong position.
Matt, that's wonderful to hear. Thanks, Angie and everyone. I'll get back in line. I appreciate the time.
Thanks, Matt. Thank you.
Hey everyone. I appreciate you taking my questions, and let me also say congrats on wrapping up the year so strongly. I've got a few things to ask about how the government shutdown affected revenue during the fourth quarter. My understanding is that you'd guided toward an impact somewhere in the range of $20 million to $24 million. Could you put a number on what the actual Q4 impact turned out to be?
Yes, our view is that, following what we saw in Q4 — and December actually came in above our expectations — we likely finished around $12 million to $15 million below where we would have been without the government impact.
Which is below what you had said, Alex. Yeah.
Yes.
Yes, correct. During the Q3 call, I believe you indicated the period from 2020 through 2024.
Correct.
That's right.
You owe that to a really strong December.
Absolutely, December performed really well. As we noted regarding the documents we reviewed, there was a comeback in October and November for active duty personnel signing up for TA courses in December. On top of that, we experienced greater momentum from veterans and military families than in earlier quarters. That group is expanding and building steam. For us, December stood out as an exceptionally robust month within that quarter.
All right. In answering an earlier question, I believe Gary mentioned that the partial shutdown had some effect during Q1. Could you say more about that?
Okay, I'll go ahead and kick things off. For anyone tracking this closely — and Alex, I know you're one of them — the Coast Guard receives its TA money through the Department of Homeland Security. That department still hasn't had its funding sorted out. As a result, a portion of Coast Guard students — and the Coast Guard is by far the smallest of all our branches — are still sitting around waiting on their funding. They've been drawing on certain OBBBA funds so those students can keep taking courses. That was one tiny blip, but it's already baked into the figures we gave you, since our Q1 for APUS is an actual, which doesn't normally happen; it's simply a matter of where the call fell on the calendar that we've got the entirety of Q1 for APUS included. The other minor blip came during that really brief stretch when funding was absent — army reservists who weren't deployed on military activities likewise went unfunded. These are quite small student populations. We didn't make a big deal of flagging them, but had everyone been able to fully enroll, it would have affected APUS's potential registration actuals for Q1 by roughly 1% to 1.5%.
I appreciate that context. Just so I understand the segment reporting structure from here on — since this was Q4, the segments you disclosed were APUS, RU, and Hondros.
Exactly.
What the guidance lays out is APEI, APU Global, and after that RU Health Plus. That is how things are going to look from here on. This marks the final time all 3 segments get their own separate reporting.
Correct; once we adopt that different cadence, we'll definitely present the comparison by merging Rasmussen and Hondros into the RU Health Plus segment. Apart from that, nothing else is really shifting, except that during the first half of 2026, as I said to a few people ahead of you, revenue from Graduate School is still part of the first half of 2026. We'll explain more clearly how to approach what that baseline comparison for 2025 ought to be when looking at the first half of 2025 against the first half of 2026, since it's obvious we no longer have that revenue available.
Gotcha. You did say what the Q1 of 2025 revenue was for?
We did. Yeah.
For graduate school.
Yes, I did. While I was reviewing the PowerPoint, it struck me that for the entire year, we hadn't provided that comparable figure. That amount was — yeah, it came to $3.7 million in revenue from graduate school, which, you know, you would subtract from the $164.6 million so that the comparison is more apples to apples.
Understood, that's useful. One final thing on that same topic: after you've finished merging those institutions under a single OPE ID number, are you still going to report both segments separately? Since that's how you—
We will. Yes.
Yes.
Yes, that is certainly something we're going to do. Yes.
Understood. All right, that sounds excellent. I'll save my remaining questions for a separate conversation. Thanks once more, and congratulations.
Thank you so much, Alex. Thank you very much.
That wraps up the Q&A portion. Everyone, we're now finished with the APEI fourth quarter 2025 earnings call. We appreciate everyone for being with us. You're free to disconnect at this point.
Read the full transcript via the API
You're viewing the first half of this call. Get the complete American Public Education, Inc. transcript - plus 132,000+ transcripts from 7,000+ companies, speaker segments and full-text search - through the EarningsAPI REST API or hosted MCP server.
Get an API key View API docs →For developers and AI pipelines
Programmatic access to American Public Education, Inc. earnings transcripts and 132,000+ others is available through the
EarningsAPI REST API and the hosted MCP server.
Quarterly plans from $162 - full transcripts, speaker segments, full-text search,
and the /api/v1/transcripts/recent polling endpoint for ETL pipelines.